Sangamo Therapeutics, Inc. Company Information
Sangamo Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Sangamo Therapeutics, Inc.
- Ticker: GBY
- Exchange: DB
- Founded: 1995
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$107.441m
- Listing Market Cap: US$100.436m
- Shares Outstanding: 207.50m
- Website: https://www.sangamo.com
Number of Employees
Location
- Sangamo Therapeutics, Inc.
- 501 Canal Blvd
- Richmond
- California
- 94804
- United States
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
SGMO | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Apr 2000 |
GBY | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Apr 2000 |
GBY | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Apr 2000 |
0R1D | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Apr 2000 |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/28 00:00 |
End of Day Share Price | 2024/04/26 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.